WAHTN Website

Category: News

  • Kidney Disease Grant Opportunity

    Australia is facing a kidney disease crisis – one in three adults are at risk of chronic kidney disease, one in ten have early signs of disease and more than 1.5 million have no idea they have chronic kidney disease.

    The Action Plan for Kidney Disease Strategy (draft) has three priority areas with nine corresponding objectives and 34 individual action items for implementation by the Australian Government, State and Territories, the healthcare and research sectors and  chronic disease and consumer peak bodies. It’s anticipated the Action Plan will be released in March 2020.

    The Kidney Disease Key Activities grant is to provide optimal care and support for patients, families and carers of those with kidney disease, health professional education and improve research and data on kidney disease.

    To be eligible you must:

    • Have an Australian Business Number (ABN)
    • Be registered for the purposes of GST
    • Be a permanent resident of Australia
    • Have an account with an Australian financial institution

    and be one of the following entity types:

    • A company incorporated in Australia
    • A company incorporated by guarantee
    • An incorporated trustee on behalf of a trust
    • An incorporated association
    • A partnership
    • A join (consortia) application with a lead organisation
    • An Australian local government body
    • An Australian state or territory government body
    • An Aboriginal and/or Torres Strait Islander Corporation registered under the Corporations Act 2006

     

    The total amount available is $2.25 million, with the estimated grant value starting from $250,000.

    Applications close Thursday February 13 at 11am (AWST). Click here for more information

     

  • WA Child Research Fund 2019/20 Now Open

    The WA Department of Health in conjunction with the Channel 7 Telethon Trust has announced the eighth round of the WA Child Research Fund (formerly the Telethon-Perth Children’s Hospital Research Fund) is now open for applications, with funding to be awarded in 2020.

    Funded research activities may be wide-ranging but must address areas of direct significance to child and adolescent health. Research may include basic, clinical, health service, or population health research.

    If you need assistance navigating the new Consumer and Community Involvement criteria please contact the Consumer & Community Health Research Network.

    Click here for further information, along with the Guidelines and Conditions and the Application Form.

    If you have any questions please contact the Research Development Unit.

     

    Closing date is 1pm, Friday 28 February 2020.

  • Prof Fiona Wood appointed to National Science and Technology Council

    Congratulations to Professor Fiona Wood AM who has been appointed to the National Science and Technology Council (NSTC), the Council providing advice to the Prime Minister and other Ministers on science and technology issues facing Australia.

    Professor Wood is Director of the Burns Service of Western Australia, co-founder of the Fiona Wood Foundation, and has a four-year appointment on the NSTC. Professor Wood replaces Professor Ian Frazer AC on the Council, and is well placed to advise the Australian Government with her background as a burns surgeon and researcher.

     

    Read the full media statement

  • Ovarian Cancer Research Grant Opportunity (EPCDR Initiative)

    The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research (EPCDR) Initiative aims to enable or support:

    • High quality biomedical, clinical, health services and/or population health research which improves patient care
    • Translation of new discoveries into clinical practice
    • New diagnoses, treatments and cures to those suffering from rare and debilitating conditions
    • Joint collaboration of consumers and researchers in undertaking research in emerging priority areas, and
    • Many Australians with debilitating conditions

     

    The objectives of the 2019 Ovarian Cancer Research grant opportunity aims to:

    • Facilitate innovative, high quality research which will lead to:
      • Improved diagnosis and treatment of ovarian cancer
      • Research which will address the gaps in research, leading to a better understanding of the causes and underlying factors which contribute to the development and progression of ovarian cancer
      • Facilitate consumer involvement in the design and evaluation of the research project (including participation in the conduct of the research)
      • Provide high-quality evidence for the new health treatments and/or drugs (where appropriate)
      • Enable rapid translation of consumer-relevant research into clinical practice, health policy and/or health advice which will lead to positive impacts for consumers
      • Encourage the development of multi-disciplinary research teams which deliver measurable outcomes which are a priority for consumers
      • Encourage collaboration between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare)

     

    The total amount available is $20 million. Applications must be submitted electronically via the Research Grants Management System (RGMS).

    Applications close 2pm (AWST), Wednesday 5 February, 2020. More information

  • Dialysis patient hope as world-first trial tracks breakthrough in infection testing

    A world first project – led by Sir Charles Gairdner Hospital Consultant Nephroloigst Dr Aron Chakera – centres on two tests which have the potential to minimise complications of the more lifestyle friendly form of dialysis.

    Peritoneal Dialysis (PD) can offer patients a better quality of life than conventional haemodialysis because it can be delivered outside the clinical setting. PD offers great flexibility for dialysis patients to pursue everyday activities, including employment. Haemodialysis is usually undertaken for periods of four to five hours at a time, three times a week, all year. It’s rarely available outside a hospital setting, preventing many patients from travelling far from their treating hospitals.

    Doctors and patients are often wary of PD due to its heightened association with peritonitis – an infection within the abdomen – which can lead to treatment failure and death. What can make peritonitis fatal is determining the cause of infection can take time and delays the start of appropriate treatment. These delays can be even longer for patients living in remote areas.

    Dr Chakera and his research team believe the solution could lie in two tests which slash the time taken to identify the cause of infection, enabling earlier treatment and reduced severity of infection.

    One of the new tests is used like a home pregnancy test, with the appearance to two lines in a panel providing almost immediate confirmation of infection. The second test which has been developed in Western Australia by PathWest scientists, can not only reduce the wait time for a diagnosis by hours or even days but also predict antibiotic resistance.

     

    Read the full media statement

  • Discovery Indigenous Funding 2021

    The Discovery Indigenous scheme provides grant funding to support research projects led by an Aboriginal and Torres Strait Islander researcher.

     

    The scheme aims to:

    • Support excellent basic and applied research and research training by Aboriginal and Torres Strait Islander researchers as individuals and as teams
    • Support national and international research collaboration
    • Enhance the scale and focus of research in Australian Government priority areas
    • Support and retain established Aboriginal and Torres Strait Islander researchers in higher education institutions

     

    The intended outcomes of the scheme are:

    • Expanded knowledge base and research capacity in Australia
    • Economic, commercial, environmental, social and/or cultural benefits for Australia

     

    To be eligible the application must:

    • Be submitted through the Research Office of an Eligible Organisation listed in the Grant Guidelines
    • Must nominate at least one Chief Investigator (CI) or a Discovery Aboriginal and Torres Strait Islander Award (DAATSIA) candidate
    • The first named CI must be an Aboriginal and Torres Strait Islander researcher and will be the Project Leader
    • To be eligible to apply as a DAATSIA candidate, the individual nominated must be an Aboriginal and Torres Strait Islander
      • As at the grant opportunity closing date not be nominated for more than one DAATSIA in any given year
    • To be eligible to apply as a CI, DAATSIA candidate or Partner Investigator (PI), the individual nominated must as the grant opportunity closing date:
      • Have met their obligations regarding previously funded projects, including submission to the ARC of satisfactory final reports
    • A CI or DAATSIA candidate must meet at lest one of the following criteria at the grant commencement date:
      • Be an employee for at least 20% full time equivalent (0.2 FTE) at an Eligible Organisation
      • Or be a holder of an honorary academic appointment at an Eligible Organisation

    For further eligibility requirements please read the Grant Guidelines

     

    Application Submission Instructions:

    • Must be submitted as a mature research plan presenting the proposed project ready for implementation and must contain all the information necessary for its assessment without the need for further written or oral explanation, or reference to additional documentation (unless requested by the ARC)
    • Applicants should note the eligibility criteria for access to other funding schemes, as expressed in the Grant Guidelines for those schemes
    • Administering Organisations must submit applications through the Research Management System (RMS) unless otherwise advised by the ARC
    • All applications must meet the format and content requirements, including certification, as set out in the RMS online form and the Instructions to Applicants for Discovery Indigenous for funding commencing in 2021

     

    There is between $30,000 up to $2.5 million available for funding.

     

    Applications close 2pm (AWST), Wednesday 18 March, 2020. Read more information

  • Endometriosis Research Grant Opportunity (EPCDR Initiative)

    The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research (EPCDR) Initiative aims to enable or support:

    • High quality biomedical, clinical, health services and/or population health research which improves patient care
    • Translation of new discoveries into clinical practice
    • New diagnoses, treatments and cures to those suffering from rare and debilitating conditions
    • Joint collaboration of consumers and researchers in undertaking research in emerging priority areas, and
    • Many Australians with debilitating conditions

     

    The objectives of the 2019 Endometriosis Research grant opportunity aims to:

    • Facilitate innovative, high quality research which will lead to:
      • Improved diagnosis and treatment of endometriosis
      • Research which will address the gaps in research, leading to a better understanding of the causes and underlying factors which contribute to the development and progression of endometriosis
      • Facilitate consumer involvement in the design and evaluation of the research project (including participation in the conduct of the research)
      • Provide high-quality evidence for the new health treatments and/or drugs (where appropriate)
      • Enable rapid translation of consumer-relevant research into clinical practice, health policy and/or health advice which will lead to positive impacts for consumers
      • Encourage the development of multi-disciplinary research teams which deliver measurable outcomes which are a priority for consumers
      • Encourage collaboration between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare)

     

    The total amount available is $9 million. Applications must be submitted electronically via the Research Grants Management System (RGMS). More information

     

    Applications are now open, with minimum data due 22 January, 2020. Applications close 2pm (AWST), Wednesday 5 February, 2020.

     

     

  • Lions Eye Institute Research Week Lectures now free to view

    Good eye sight plays an integral role in people’s quality of life. The Lions Eye Institute (LEI) shares important developments in research into vision loss and blindness during its inaugural LEI Research Week. LEI hosted a series of free lectures during their Research Week, and have made the below available for viewing.

     

    The videos now available for viewing include:

  • Fetal Alcohol Spectrum Disorder (FASD) Grant Opportunities

    There are two grant opportunities in the Fetal Alcohol Spectrum Disorder (FASD) space in the category of Health Promotion and Prevention Programs.

     

    • FASD – Consumer Resources – the purpose of this opportunity is to develop FASD consumer resources to increase the general awareness of FASD, and contribute to the prevention of FASD, as well as outline the potential consequences of drinking whilst pregnant.

     

    • FASD – Early Childhood Identification Guide – the purpose of this opportunity is to develop a FASD Guide for people working in early childhood education settings. The FASD Guide is to support educators to assist children with FASD, and to encourage positive outcomes for children and their families.

     

    Applications for both close on 11am (WST), Tuesday January 10. Click the links above for more information.

  • CT:IQ – Clinical Trials: Thinking Smarter Survey

    CT:IQ Clinical Trials: Thinking Smarter is a cross industry, collaborative group which aims to improve recruitment into clinical trials within Australia. As a part of this project the team are seeking opinions from all parts of the community, including researchers, clinicians, consumers and community members on the barriers and enablers to a site which will be designed to recruite participtants to clinical trials.

     

    The introduction of the survey provides details of the project, confidentiality and privacy of responses. The survey will take approximately 10-20 minutes to complete.

    The survey will close on Saturday November 30.

    Click here to take the Survey

     

    The ethical conduct of this survey has been approved by the Macquarie University Human Research Ethics Committee (Project ID 5764) and will be carried out according to the National Statement on Ethical Conduct in Human Research (2007) produced by the NHMRC.

     

    If you have any questions about this survey or the project please contact the CT:IQ Project Manager, Sonia Harvey

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by